We share some thoughts on #nemolizumab #IL31RA #mAb as a promising and exciting new therapy for #atopic #dermatitis and #prurigo #nodularis. The first #cytokine #pruritogen #IL31https://www.sciencedirect.com/science/article/pii/S009167492400232X

Choragudi et al. studied how specific types of #pruritus affect inpatient burden in the US. They found #prurigo nodularis/lichen simplex chronicus, pruritus ani, and #genital pruritus were linked to higher odds of #psychiatric #hospitalization 👉bit.ly/48posRz

If I told you 10 years ago that the word #neuroimmune with a picture of a patient with #prurigo #nodularis would be displayed by a #pharmaceutical company at @AADskin, 9 out of 10 people would have laughed me out of the room. #neuroimmunology is real #itch is real

Excited to be speaking at #aad2024 and sharing my insights on all things #itch #eczema #prurigo. Hope to see many of you there!

Prurigo Nodularis occurs when you get trapped in an itch-scratch cycle - scratching causes itchy calluses which keep getting thicker to protect from your scratching! This is a case showing good response with Dupilumab injections, topical steroids and Phototherapy. #prurigo #itch

Company reveals submission for #Nemolizumab for two conditions: #prurigo #nodularis and for moderate to severe #atopic #dermatitis. Stay updated! #healthcare #innovation bit.ly/48oxsGG

.@galderma Announces Regulatory Filing Acceptance for #Nemolizumab in #Prurigo #Nodularis and #Atopic #Dermatitis in the U.S. and EU - check the link for more ow.ly/5Ii250QBeA7 #rarediseases #orphandrugs

Halo guys, ada yang tau / punya darah manis? Gimana ya cara hilangin bekas luka di kaki atau di tangan, butuh review jujur ya, yang work dan bekas nya beneran bisa hilang di aku, bakal aku kasih hadiah, soalnya udah risih banget ama kondisi ini wkwk.. #darahmanis #prurigo

#eczema, #prurigo, and #urticaria are all very #itchy and respond to the same #type2 #cytokine blockers. Yet they are vastly different #diseases with different #lesions and even different #itches. #neuroimmune is simultaneously complex but also incredibly amenable to #therapy.

💊Neuer Therapieansatz gegen #Prurigo nodularis (PN): In einer Phase-3-Studie führte der IL-31-Rezeptor-Antagonist im Placebovergleich zu einer signifikanten Reduktion der Pruritusintensität und der Hautläsionen. bit.ly/3sH1zKx (nach Reg.) #juckreiz

For #prurigo #nodularis drug gets denied because of lack of documentation of secondary endpoint (#nodules) despite documentation of primary endpoint (#itch). However secondary endpoint (itch) in #eczema carries zero weight for drug approval…despite being primary symptom. We have…

Celldex is reporting that c-Kit blockade is improving #prurigo #nodularis. Why? We think because of the right side of this illustration. @JillGMedArt

Back in Vegas with @MedscapeLIVE hanging with the crew Lawrence Eichenfield, @patchtestYu, @_AprilArmstrong, Peter Lio, & Adam Friedman to talk all about #eczema, #itch, #prurigo, & beyond! #LVDlive23

keyboard_arrow_left Previous keyboard_arrow_right Next

Check out our study published today in @NEJM on #nemolizumab for #prurigo nodularis bitly.ws/YxfA. The rapidity of itch reduction is a seismic finding that will send shockwaves reverberating throughout all of the itch & dermatology worlds. A huge win for itch patients!

New study alert 🚨📜   In this original investigation led by the talented @rajehTea, we perform a first-ever comprehensive somatic mutational analysis of #prurigo nodularis, challenging our understanding of the dz.   Paper: bitly.ws/XwxA   🧵 a few takeaways below 1/8

What a huge honor to present at the @eadv’s plenary session to share data from our phase 2 trial of abrocitinib in the management of #Prurigo Nodularis and Chronic Pruritus of Unknown Origin. The translational revolution in #itch is advancing rapidly! #EADV2023 #dermtwitter

keyboard_arrow_left Previous keyboard_arrow_right Next

Please join me tomorrow in Berlin at the @eadv along with Elke Weisshaar and Sonja Stander as I discuss new insights into #neuropathic #itch #burden and #dupilumab for #prurigo and why #TCS and #TCI background makes the signal in #dupilumab even cleaner

DUPIXENT (dupilumab) autorisation d’accès précoce renouvelée dans l’indication « traitement du #prurigo nodulaire modéré à sévère de l’adulte qui nécessite un traitement systémique » has-sante.fr/jcms/p_3465275…